# JIANYI CAPITAL

> JIANYI CAPITAL is a VC fund backing Medical, Biotechnology and Biopharma. See 4 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 4
- Last investment: Sep 2023
- Lead investor: 25%
- Last updated: Aug 2026

JIANYI CAPITAL is a VC fund focused on Medical and Biotechnology. JIANYI CAPITAL

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 75% |
| Biotechnology | 3 | 75% |
| Biopharma | 1 | 25% |
| Health Care | 1 | 25% |
| Life Science | 1 | 25% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 50% |
| Series A | 1 | 25% |
| Series B | 1 | 25% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Leo Summit | Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Providesystematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing. |  | Seed | Sep 08, 2023 |  |
| Yuce Biotechnology | Yuce Biotechnology is a high-tech company focused on the industrialization of single-molecule immunodiagnostic technologies. | $14.9M | Series A | Jun 29, 2022 |  |
| Brise Pharma | Brise Pharma operates in the scientific research and technical service industry. | $156.9M | Seed | Mar 28, 2022 |  |
| Singlomics | Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers. | $47.2M | Series B | Feb 02, 2022 |  |

4 of 4 investments shown.

## Co-investors
- [Boyuan Capital](https://shizune.co/investors/profile/boyuan-capital-4fca) — VC Fund, 2 deals together
- [Huagai Capital](https://shizune.co/investors/profile/huagai-capital) — VC Fund, 2 deals together
- [BOHE Angel Fund](https://shizune.co/investors/profile/bohe-angel-fund) — VC Fund, 1 deal together
- [CASH Capital](https://shizune.co/investors/profile/cash-capital) — VC Fund, 1 deal together
- [Founder H Fund](https://shizune.co/investors/profile/founder-h-fund) — VC Fund, 1 deal together
- [GL Ventures](https://shizune.co/investors/profile/gl-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)

## FAQ

### What does JIANYI CAPITAL invest in?

JIANYI CAPITAL invests primarily in Medical, Biotechnology and Biopharma startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did JIANYI CAPITAL last invest?

The most recent investment recorded for JIANYI CAPITAL closed in Sep 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co